Thalidomide

[XFB] Konu Bilgileri

Konu Hakkında Merhaba, tarihinde Wiki kategorisinde News tarafından oluşturulan Thalidomide başlıklı konuyu okuyorsunuz. Bu konu şimdiye dek 1 kez görüntülenmiş, 0 yorum ve 0 tepki puanı almıştır...
Kategori Adı Wiki
Konu Başlığı Thalidomide
Konbuyu başlatan News
Başlangıç tarihi
Cevaplar
Görüntüleme
İlk mesaj tepki puanı
Son Mesaj Yazan News

News

Moderator
Top Poster Of Month
Credits
0
Chemistry: add notable one-step reaction procedure

← Previous revision
Revision as of 12:07, 7 May 2024
Line 157:Line 157:
[[Celgene Corporation]] originally synthesized thalidomide using a three-step sequence starting with [[Glutamate|<small>L</small>-glutamic acid]] treatment, but this has since been reformed by the use of [[Glutamine|<small>L</small>-glutamine]].<ref name="synth">{{cite journal| vauthors = Muller GW, Konnecke WE, Smith "*****", Khetani VD | date=19 March 1999|title=A Concise Two-Step Synthesis of Thalidomide | journal=Organic Process Research & Development|volume=3|issue=2|pages=139–140|doi=10.1021/op980201b }}</ref> As shown in the image below, ''N''-carbethoxyphthalimide (1) can react with <small>L</small>-glutamine to yield ''N''-phthaloyl-<small>L</small>-glutamine (2). Cyclization of ''N''-phthaloyl-<small>L</small>-glutamine occurs using [[carbonyldiimidazole]], which then yields thalidomide (3).<ref name="synth" /> Celgene Corporation's original method resulted in a 31% yield of ''S''-thalidomide, whereas the two-step synthesis yields 85–93% product that is 99% pure.[[Celgene Corporation]] originally synthesized thalidomide using a three-step sequence starting with [[Glutamate|<small>L</small>-glutamic acid]] treatment, but this has since been reformed by the use of [[Glutamine|<small>L</small>-glutamine]].<ref name="synth">{{cite journal| vauthors = Muller GW, Konnecke WE, Smith "*****", Khetani VD | date=19 March 1999|title=A Concise Two-Step Synthesis of Thalidomide | journal=Organic Process Research & Development|volume=3|issue=2|pages=139–140|doi=10.1021/op980201b }}</ref> As shown in the image below, ''N''-carbethoxyphthalimide (1) can react with <small>L</small>-glutamine to yield ''N''-phthaloyl-<small>L</small>-glutamine (2). Cyclization of ''N''-phthaloyl-<small>L</small>-glutamine occurs using [[carbonyldiimidazole]], which then yields thalidomide (3).<ref name="synth" /> Celgene Corporation's original method resulted in a 31% yield of ''S''-thalidomide, whereas the two-step synthesis yields 85–93% product that is 99% pure.
In 2023, it is reported that [[phthalic anhydride]] and [[Glutamine|<small>L</small>-glutamine]] under suitable conditions can react directly to form thalidomide. In the procedure, phthalic anhydride and <small>L</small>-glutamine are grounded and added into [[toluene]] solvent. The solution, along with [[triethylamine]] and [[acetic anhydride]], is refluxed at ~110°C for 9 hours; after that the solution goes though a simple [[vacuum filtration]] procedure to obtain the product.<ref>{{Cite journal |last=Savini |first=Emanuel Bruno |last2=Bandieri |first2=Edoardo |date=2023 |title=One step synthesis of thalidomide |url=https://cssp.chemspider.com/Article.aspx?id=964 |journal=[[ChemSpider]] |language=en}}</ref>
[[File:Thalidomide_syntehsis.png|center|thumb|567x567px|Muller et al.'s two-step thalidomide synthesis]][[File:Thalidomide_syntehsis.png|center|thumb|567x567px|Muller et al.'s two-step thalidomide synthesis]]

Okumaya devam et...
 

Geri
Üst